Healthcare Tips: Austrian biotech plans Zika vaccine clinical trials in 12 months

(Reuters) - An Austrian biotech company working with the Institut Pasteur said on Tuesday it planned to start clinical trials with an experimental Zika vaccine in the next 12 months, marking a further acceleration of research in the field.

Read more: Austrian biotech plans Zika vaccine clinical trials in 12 months